According to Codexis 's latest financial reports the company's current earnings (TTM) are -$76.18 M. In 2022 the company made an earning of -$33.32 M a decrease over its 2021 earnings that were of -$21.1 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$76.18 M | 128.63% |
2022 | -$33.32 M | 57.96% |
2021 | -$21.1 M | -10.9% |
2020 | -$23.68 M | 98.62% |
2019 | -$11.92 M | 9.18% |
2018 | -$10.92 M | -52.36% |
2017 | -$22.92 M | 166.52% |
2016 | -$8.6 M | 8.57% |
2015 | -$7.92 M | -59.03% |
2014 | -$19.33 M | -53.31% |
2013 | -$41.4 M | 35.33% |
2012 | -$30.59 M | 87.55% |
2011 | -$16.31 M | 99.94% |
2010 | -$8.16 M | -59.66% |
2009 | -$20.23 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Pfizer PFE | $3.26 B | -4,389.03% | ๐บ๐ธ USA |
Merck MRK | $3.03 B | -4,084.46% | ๐บ๐ธ USA |
Dupont De Nemours DD | $0.50 B | -761.67% | ๐บ๐ธ USA |
Balchem BCPC | $0.15 B | -309.89% | ๐บ๐ธ USA |